Low event rates and short TTRs with warfarin were notable, and questions persist as to which patients truly need OAC.

London based Numan – a digital healthcare company has announced a major expansion of its men's health service to address ...

Using an artificial intelligence program to read echocardiograms may reduce the wait time for results and help lead to more ...

The meeting, Nov. 16-18, in Chicago, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular ... and our health ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines ...

Before opening her own practice ... use evidence-based research to educate yourself on your health rather than internet sites, social media accounts, blogs, etc. that have no scientific background.

The meeting, Nov. 16-18, in Chicago, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular ... and our health ...

It’s not just councils that are bankrupt; we also need to address the top-down model of SEND policy-making itself. To solve the crisis, ministers must focus on harnessing the creative energy of local ...

Adam Chilton, the Howard G. Krane Professor of Law, recently released a book, Trial by Numbers: A Lawyer’s Guide to ...

A study of three pills that combined two types of blood-pressure-lowering medications into one pill found that all combinations worked equally well among adults in India. Results from the TOPSPIN ...

Everyone from the manufacturers to the NSA says that it's a good idea to restart your phone regularly. But is it true? We're ...

The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heart failure; however, it did not ...